📰 Financial TimesFinancial TimesCodex · 实盘不做把握 5/10
北京时间·🕒 发布 03:12:50时区推断·⟳ 抓取 03:13:18·⚡ 决策 08-01 03:37:00 +23m42s·87.9 天前
KKR接近以每股125至130美元收购医疗器械代工商Integer
FT称KKR接近以每股125至130美元、最高约44亿美元收购Integer，较报道中约34亿美元市值存在明确溢价。
📄 原文Financial Times↗ 原文
KKR nears deal to buy medical device maker Integer for more than $4bn
Private equity group KKR is nearing a more than $4bn take-private deal for a healthcare company recently targeted by an…
不做 Integer Holdings（ITGR.US）
收购溢价逻辑成立但stock_quote连续504，无法取得真实现价和剩余价差，按ENTER必须有真实报价的契约当前不做。
不做 KKR（KKR.US）
作为收购方缺少短线市值级正向增量，且交易未正式确认，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-31 · 扩散 low · price-in 风险 medium ↗
消息传播链
- FT报道称KKR接近以每股125至130美元、最高44亿美元收购Integer，交易最早可能周一达成。市场反应:未能取得ITGR.US实时行情，无法确认报道后盘中反应。
- 报道称KKR拒绝置评，Integer未回应置评请求，说明尚无当事方正式确认。
关键理由
- FT称KKR接近以每股125至130美元、最高约44亿美元收购Integer，较报道中约34亿美元市值存在明确溢价。
- 事件是目标公司层面的直接收购溢价利好，但尚未正式签署，报道称最早可能周一达成且仍有其他竞购方。
- 当前美国市场仍在交易时段，若股价已快速贴近要约区间，剩余套利空间会明显收窄。
主要风险
- 交易尚未正式同意，KKR和Integer未确认，存在谈判破裂或最终价格低于报道区间的风险。
- stock_quote连续返回504，无法取得ITGR.US真实现价和前收，按系统契约不能给可执行ENTER。
反向证据
- 做多前查反向 · 来源 kb_search · 影响 none
kb_search服务504，未能补充旧闻、反证或交易失败风险材料。
检索:Integer Holdings KKR take private deal $125 $130 Irenic activist - 做多前查反向 · 来源 stock_quote · 影响 invalidates
stock_quote对ITGR.US返回HTTP 504，无法取得真实现价、前收和涨跌幅。
检索:ITGR.US stock_quote full
工具调用 · 历史记录,结果未知(5 种)
- search_processed_events · 结果未知
- stock_quote · 结果未知
- kb_search · 结果未知
- search_case_library · 结果未知
- price_snapshot · 结果未知
原文全文
展开原文 · 1,023 字
KKR nears deal to buy medical device maker Integer for more than $4bn
Private equity group KKR is nearing a more than $4bn take-private deal for a healthcare company recently targeted by an activist hedge fund set up by an Elliott Management alumnus.
Contract medical device manufacturer Integer Holdings was nearing a deal to sell to KKR for between $125-$130 a share, or as much as $4.4bn, according to people familiar with the matter, a premium to its $3.4bn market value on Friday afternoon.
Talks were ongoing but a deal could come together as soon as Monday, the people said. Other suitors were circling Integer and a deal had yet to be formally agreed.
The takeover bid comes after Integer struck a brokered peace with Irenic Capital Management to add two directors to its board after the activist investor built a 3 per cent stake in the company. Irenic was set up by Adam Katz, a former Elliott portfolio manager.
KKR declined to comment. Integer did not respond to requests for comment.
This is a developing story
Private equity group KKR is nearing a more than $4bn take-private deal for a healthcare company recently targeted by an activist hedge fund set up by an Elliott Management alumnus.
Contract medical device manufacturer Integer Holdings was nearing a deal to sell to KKR for between $125-$130 a share, or as much as $4.4bn, according to people familiar with the matter, a premium to its $3.4bn market value on Friday afternoon.
Talks were ongoing but a deal could come together as soon as Monday, the people said. Other suitors were circling Integer and a deal had yet to be formally agreed.
The takeover bid comes after Integer struck a brokered peace with Irenic Capital Management to add two directors to its board after the activist investor built a 3 per cent stake in the company. Irenic was set up by Adam Katz, a former Elliott portfolio manager.
KKR declined to comment. Integer did not respond to requests for comment.
This is a developing story
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。